Phase 1 Congestive Heart Failure Clinical Trials
4 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–4 of 4 trials
Recruiting
Phase 1Phase 2
Peritoneal Ultrafiltration in Cardio Renal Syndrome.
Congestive Heart Failure
Iperboreal Pharma Srl84 enrolled3 locationsNCT03994874
Recruiting
Phase 1Phase 2
Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Reduced Ejection Fraction
Heart FailureCongestive Heart FailureHFrEF - Heart Failure With Reduced Ejection Fraction+1 more
Sardocor Corp.57 enrolled5 locationsNCT04703842
Completed
Phase 1
Study to find out if the drug “Vessel Dilator” is absorbed from an infusion under the skin and is safe and tolerated and improves heart function in people diagnosed with stable congestive heart failure and a moderate degree of kidney function loss.
Stable Congestive Heart FailureRenal Impairment
Madeleine Pharmaceuticals Pty Ltd18 enrolled1 locationACTRN12612000576820
Completed
Phase 1
Reducing symptoms in acute Acute Heart Failure with a man made vessel dilator peptide
Acute Decompensated Congestive Heart Failure (ADCHF)
Madeleine Pharmaceuticals36 enrolled1 locationACTRN12609000998246